{"entity":{"type":"insider","cik":"0001707715","url":"/insider/0001707715","json_url":"/insider/0001707715.json","name":"Scadden David","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2018-03-20","last":"2025-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Scadden David","source":"filing","n_filings":8,"first_seen":"2018-03-20","last_seen":"2025-11-14"}],"transactions":[{"id":4925300,"accession":"0001439222-25-000120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000120","line_url":"/filing/0001439222-25-000120#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001707715","owner_name":"Scadden David","owner_url":"/insider/0001707715","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":43.84,"price_display":"43.84","price_state":"stated","total_value":8768.0,"total_display":"8,768.00","shares_owned_after":17603.0,"shares_owned_after_display":"17,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4689877,"accession":"0001439222-25-000108","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000108","line_url":"/filing/0001439222-25-000108#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001707715","owner_name":"Scadden David","owner_url":"/insider/0001707715","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":8200.0,"total_display":"8,200.00","shares_owned_after":17603.0,"shares_owned_after_display":"17,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-08","filed_date":"2025-10-10","scope":"insider"},{"id":4814571,"accession":"0001439222-25-000106","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000106","line_url":"/filing/0001439222-25-000106#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001707715","owner_name":"Scadden David","owner_url":"/insider/0001707715","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","shares_owned_after":17603.0,"shares_owned_after_display":"17,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-30","filed_date":"2025-10-02","scope":"insider"},{"id":4435904,"accession":"0001439222-25-000100","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000100","line_url":"/filing/0001439222-25-000100#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001707715","owner_name":"Scadden David","owner_url":"/insider/0001707715","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":8000.0,"total_display":"8,000.00","shares_owned_after":17603.0,"shares_owned_after_display":"17,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-29","scope":"insider"},{"id":4596328,"accession":"0001439222-25-000084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-25-000084","line_url":"/filing/0001439222-25-000084#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001707715","owner_name":"Scadden David","owner_url":"/insider/0001707715","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":56000.0,"total_display":"56,000.00","shares_owned_after":17603.0,"shares_owned_after_display":"17,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-10","filed_date":"2025-07-15","scope":"insider"},{"id":2354910,"accession":"0001439222-24-000146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001439222-24-000146","line_url":"/filing/0001439222-24-000146#line-2","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS, INC.","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001707715","owner_name":"Scadden David","owner_url":"/insider/0001707715","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":46.28,"price_display":"46.28","price_state":"stated","total_value":9256.0,"total_display":"9,256.00","shares_owned_after":15483.0,"shares_owned_after_display":"15,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-11","filed_date":"2024-12-13","scope":"insider"},{"id":6568999,"accession":"0000899243-18-018341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-018341","line_url":"/filing/0000899243-18-018341#line-2","is_derivative":false,"issuer_cik":"0001690585","issuer_name":"Magenta Therapeutics, Inc.","issuer_ticker":"MGTA","issuer_name_source":null,"issuer_url":"/issuer/0001690585","owner_cik":"0001707715","owner_name":"Scadden David","owner_url":"/insider/0001707715","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6600.0,"shares_display":"6,600","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":99000.0,"total_display":"99,000.00","shares_owned_after":228175.0,"shares_owned_after_display":"228,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-27","scope":"insider"},{"id":5996096,"accession":"0001209191-18-020896","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-020896","line_url":"/filing/0001209191-18-020896#line-1","is_derivative":false,"issuer_cik":"0001439222","issuer_name":"AGIOS PHARMACEUTICALS INC","issuer_ticker":"AGIO","issuer_name_source":null,"issuer_url":"/issuer/0001439222","owner_cik":"0001707715","owner_name":"Scadden David","owner_url":"/insider/0001707715","role":"Director","officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":83.44,"price_display":"83.44","price_state":"stated","total_value":16688.0,"total_display":"16,688.00","shares_owned_after":571.0,"shares_owned_after_display":"571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-16","filed_date":"2018-03-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS, INC.","url":"/issuer/0001439222","role":"Director","n_filings":7,"first_seen":"2018-03-20","last_seen":"2025-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001690585","name":"Magenta Therapeutics, Inc.","url":"/issuer/0001690585","role":"Director","n_filings":1,"first_seen":"2018-06-27","last_seen":"2018-06-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001707715","retrieved_at":"2026-08-21T13:09:14+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}